Clinical Trials of Herpes Simplex Encephalitis: The Role of the Data Monitoring Committee
Herpes simplex encephalitis (HSE) is the most frequent cause of focal necrotizing encephalitis, accounting for approximately 2,500 cases annually in the United States. Studies initiated in the early 1970s have continuously evaluated promising antiviral drugs for the treatment of this disease, utilizing randomized, blinded, controlled clinical trial designs. Fundamental to the early studies was the requirement for brain biopsy in order to establish a diagnosis of HSE unequivocally by isolation of herpes simplex virus (HSV) from brain tissue in cell culture. From the outset of these studies in 1973, Data Monitoring Committees (DMCs) were established by the program sponsor, the National Institute of Allergy and Infectious Diseases (NIAID), to assess clinical trial performance, data quality, and outcome. With several iterations over a period of 30 years, these DMCs have terminated one trial because of excessive drug toxicity and two trials because of significantly reduced mortality in recipients of an active therapeutic. These studies represented the first clinical trials sponsored by NIAID that utilized a DMC. The role of the DMC in the monitoring of these trials is described.
KeywordsHerpes Simplex West Nile Virus Brain Biopsy Herpes Simplex Encephalitis Case Study Approach
Unable to display preview. Download preview PDF.
- 2.Longson M. The general nature of viral encephalitis in the United Kingdom. Viral Diseases of the Central Nervous System, pp. 19–31. Ellis LS. (ed.), 1984. Bailliere Tindall, London.Google Scholar
- 6.Lerner AM, Lauter CB, Nolan DC, Shippey MJ. 1972. Passive hemagglutinating antibodies in cerebrospinal fluids in herpes virus hominis encephalitis. Proc Soc Exp Biol Med 140:1460–1466.Google Scholar
- 7.Wilfert CM, Huang ES, Stagno S. 1982. Restriction endonuclease analysis of cytomegalovirus deoxyribonucleic acid as an epidemiologic tool. Pediatrics 70:717–721.Google Scholar
- 9.Boston Interhospital Virus Study Group and the NIAID Sponsored Cooperative Antiviral Clinical Study. Alford CA, Chien LT, Whitley R, et al. 1975. Failure of high dose 5-deoxyuridine in the therapy of herpes simplex virus encephalitis: Evidence of unacceptable toxicity. N Engl J Med 292:600–603.Google Scholar
- 12.McCartney JJ. 1978. Encephalitis and ara-A: An ethical case study. Hastings Cent Rep 8:5–7.Google Scholar